| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3802000 | Medicina Clínica | 2011 | 7 Pages |
Abstract
Ranibizumab was shown to be effective until 18 months. Early diagnosis of AMD could lead to an earlier treatment start, when patients present a higher AV, in order to optimize the benefits of treatment. Ranibizumab was well tolerated and safe in most patients.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
José Manuel Real Campaña, Patricia Carrera Lafuentes, Clemencia Torrón Fernández-Blanco, Rafael Huarte Lacunza, Isabel Varela MartÃnez, M. José Rabanaque Hernández,